Technology News and Research

RSS

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Following the momentum of launching an industry-defining open architecture platform, Eclipsys Corporation today announced a partnership with Rothman Healthcare Research to build its Patient Condition Tracker software solution on the Helios by Eclipsys™ platform.

29 Mar 2010

Prolucent Workforce Management acquires intellectual property assets from Symbio Solutions

Prolucent™ Workforce Management, the leading partner for healthcare providers seeking to optimize deployment of their workforce, today announced the acquisition of intellectual property assets from Symbio Solutions, Inc. The asset acquisition further strengthens Prolucent's best-of-breed workforce management software platform and will help Prolucent deliver even greater value to the more than 1,000 acute-care hospitals and staffing agencies it currently serves.

29 Mar 2010

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.

29 Mar 2010

Chakra Biotech completes MYR18.2m Series B investment round

Chakra Biotech Sdn Bhd, a Malaysian based Contract Research Organization, has completed a MYR18.2m Series B funding round. This brings total funding for the company to MYR20.0m. Malaysian Life Sciences Capital Fund Ltd. (MLSCF) and the Malaysian Technology Development Corporation Sdn Bhd (MTDC) participated in the round.

29 Mar 2010

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Oxygen Biotherapeutics, Inc. today announced that the company has begun distribution for its newly formulated Dermacyte™ Oxygen Concentrate for the beauty and skin care market. The over-the-counter product is a scientifically designed perfluorocarbon concentrate to enhance oxygen delivery to skin.

29 Mar 2010

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 1 safety and pharmacokinetics study of PT003, its lead combination therapeutic for the treatment of chronic obstructive pulmonary disease (COPD). Based on these results, and previously announced positive results from Phase 2a studies of PT003's individual components, the company has advanced PT003 into a Phase 2b trial.

29 Mar 2010

GEA Niro selects engineering simulation software from ANSYS

GEA Niro has selected engineering simulation software from ANSYS to optimize equipment design and reduce development time and costs. Based in Denmark, GEA Niro is a world market leader in drying technology for the dairy, food, pharmaceutical and chemical industries and is a core technology center in the GEA Process Engineering business segment in GEA Group.

29 Mar 2010

Three new hospitals utilize PureWellness' comprehensive online employee wellness platform

PureWellness, Inc., a leading provider of online wellness solutions, announced it has signed agreements with three new hospitals; Northeast Georgia Health Systems, McCullough-Hyde Memorial Hospital, and Fletcher Allen Health Care.

29 Mar 2010

Helmholtz Zentrum München, SIRION BIOTECH partner to develop new therapeutic approaches against lymphoid tumors

Helmholtz Zentrum München has launched a new cooperative project with SIRION BIOTECH GmbH in Martinsried to develop new therapeutic approaches against lymphoid tumors. With a two-year grant from the Federal Ministry for Economics and Technology, the two partners will seek to further develop lentiviral vector systems to better understand the disease mechanisms of this cancer form and to devise approaches for treatment.

29 Mar 2010

APP adds eClinicalWorks' EMR system to CI Program

In its continuing efforts to enhance patient outcomes and create efficiency in a challenging economic and regulatory climate, Advocate Physician Partners, has added the power of an electronic medical record system to its award-winning Clinical Integration Program. APP, the largest network of independent physicians in the Midwest, is partnering with eClinicalWorks® in one of the biggest EMR implementations in the country.

29 Mar 2010

PROCAPS granted exclusive rights to commercialize Pro-Pharmaceuticals' DAVANAT in Colombia

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANAT® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANAT® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.

29 Mar 2010

Medtronic announces settlement of lawsuit initiated against AGA Medical

Medtronic, Inc., today announced the settlement of a lawsuit it initiated against AGA Medical Corp. in 2007 for infringement of Medtronic's Jervis patent family.

29 Mar 2010

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.

29 Mar 2010

ARYx Therapeutics reports net loss of $5.8M for fourth-quarter 2009

ARYx Therapeutics, Inc. today reported results of operations and provided an update on its products for the fourth quarter and year ended December 31, 2009.

29 Mar 2010

Ten best practices for implementing statewide HIEs

With approximately $400 million in federal stimulus dollars being funneled into local governments to develop statewide health information technology programs, states are rapidly developing Health Information Exchanges to streamline information sharing and the continuity of patient care.

29 Mar 2010

iPhone can provide valuable assistance to insurance holders

Mobile devices such as the iPhone can provide valuable assistance to insurance holders in a claims situation, comparison site Constructaquote.com has said.

29 Mar 2010

DNA evidence often overwhelms jurors to convict wrongly says research

According to new reports from The Australian Institute of Criminology Research jurors are often not confident enough in their knowledge of DNA based evidence and this may often go against the accused as they may return with the guilty verdict. This is known as “the white coat syndrome” meaning laymen are often overwhelmed by the presence of an expert and as jurors may place more importance to these DNA evidence than necessary.

29 Mar 2010

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.

29 Mar 2010

BIO praises Reps. for introducing bill to extend Cellulosic Ethanol Production Tax Credit

Consistent, sustained and diverse federal support is the key to rapid growth of a sustainable advanced biofuel industry. The Biotechnology Industry Organization today thanked Reps. Earl Pomeroy (D-N.D.) and John Shimkus (R-Ill.) for introducing a bill to extend by three years the Cellulosic Ethanol Production Tax Credit. BIO also called for extending tax code parity to algae-based biofuels and a full range of innovative biobased technologies.

29 Mar 2010

Cortex signs agreement to sell certain AMPAKINE compounds to Biovail

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.

29 Mar 2010

Technology News and Research

Eclipsys, Rothman partner to build Patient Condition Tracker software solution on Helios by Eclipsys platform

Prolucent Workforce Management acquires intellectual property assets from Symbio Solutions

FDA grants SynCardia Systems conditional approval to conduct IDE study of Freedom driver system

Chakra Biotech completes MYR18.2m Series B investment round

Oxygen Biotherapeutics commences distributing newly formulated Dermacyte Oxygen Concentrate

Positive results from Pearl Therapeutics' Phase 1 study of inhaled combination bronchodilator for COPD

GEA Niro selects engineering simulation software from ANSYS

Three new hospitals utilize PureWellness' comprehensive online employee wellness platform

Helmholtz Zentrum München, SIRION BIOTECH partner to develop new therapeutic approaches against lymphoid tumors

APP adds eClinicalWorks' EMR system to CI Program

PROCAPS granted exclusive rights to commercialize Pro-Pharmaceuticals' DAVANAT in Colombia

Medtronic announces settlement of lawsuit initiated against AGA Medical

Inovio Biomedical's total revenue increased to $2.6M for quarter ended December 31, 2009

ARYx Therapeutics reports net loss of $5.8M for fourth-quarter 2009

Ten best practices for implementing statewide HIEs

iPhone can provide valuable assistance to insurance holders

DNA evidence often overwhelms jurors to convict wrongly says research

Cardima announces CE Mark approval for Surgical Ablation Probe in Surgical Treatment of Atrial Fibrillation

BIO praises Reps. for introducing bill to extend Cellulosic Ethanol Production Tax Credit

Cortex signs agreement to sell certain AMPAKINE compounds to Biovail

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News